Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nicolas Mach

Preoperative Chemotherapy and Radiotherapy Concomitant to Cetuximab in Resectable Stage IIIB NSCLC: A Multicentre Phase 2 Trial (SAKK 16/08)

British Journal of Cancer

Cancer Research

Oncology

2019

English

Phase I Trial of Concomitant Hyperfractionated Radiotherapy With Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

English

Related publications

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology

English

Pre-Operative Chemotherapy in Early Stage Resectable Non-Small-Cell Lung Cancer: A Randomized Feasibility Study Justifying a Multicentre Phase III Trial

British Journal of Cancer

Cancer Research

Oncology

1999

English

126TiP SAKK 16/14: Anti-Pd-L1 Antibody Durvalumab (MEDI4736) in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC): A Multicenter Single-Arm Phase II Trial

Journal of Thoracic Oncology

English

P2.16-03 CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC

Journal of Thoracic Oncology

English

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology

English

A Phase II Study of Cetuximab, Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer

European Journal of Surgical Oncology

English

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

British Journal of Cancer

Cancer Research

Oncology

2007

English

Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

Oncology Research and Treatment

English

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nicolas Mach

Preoperative Chemotherapy and Radiotherapy Concomitant to Cetuximab in Resectable Stage IIIB NSCLC: A Multicentre Phase 2 Trial (SAKK 16/08)

Phase I Trial of Concomitant Hyperfractionated Radiotherapy With Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Related publications

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Pre-Operative Chemotherapy in Early Stage Resectable Non-Small-Cell Lung Cancer: A Randomized Feasibility Study Justifying a Multicentre Phase III Trial

126TiP SAKK 16/14: Anti-Pd-L1 Antibody Durvalumab (MEDI4736) in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC): A Multicenter Single-Arm Phase II Trial

P2.16-03 CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

A Phase II Study of Cetuximab, Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy